Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Services (HCSG) Amortizatization of Intangibles (2016 - 2025)

Healthcare Services (HCSG) has disclosed Amortizatization of Intangibles for 17 consecutive years, with -$64000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Amortizatization of Intangibles fell 112.77% to -$64000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $295000.0, a 80.39% decrease, with the full-year FY2025 number at $295000.0, down 80.39% from a year prior.
  • Amortizatization of Intangibles was -$64000.0 for Q4 2025 at Healthcare Services, down from $124000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $602000.0 in Q2 2021 to a low of -$64000.0 in Q4 2025.
  • A 5-year average of $421850.0 and a median of $535000.0 in 2021 define the central range for Amortizatization of Intangibles.
  • Peak YoY movement for Amortizatization of Intangibles: skyrocketed 31.15% in 2021, then tumbled 112.77% in 2025.
  • Healthcare Services' Amortizatization of Intangibles stood at $535000.0 in 2021, then increased by 2.06% to $546000.0 in 2022, then decreased by 2.01% to $535000.0 in 2023, then dropped by 6.36% to $501000.0 in 2024, then plummeted by 112.77% to -$64000.0 in 2025.
  • Per Business Quant, the three most recent readings for HCSG's Amortizatization of Intangibles are -$64000.0 (Q4 2025), $124000.0 (Q3 2025), and $118000.0 (Q2 2025).